D-DOPA
Product Specifications
CAS Number
5796-17-8
Target
Carboxypeptidase, Others
Related Pathways
Proteases/Proteasome, Others
Bioactivity
D-DOPA is an enantiomer of the dopamine precursor L-DOPA . It can be converted to L-DOPAviasequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.1It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.2Intraventricular administration of D-DOPA (200 μg/animal) increases striatal dopamine levels in rats.3D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson's disease induced by 6-OHDA .4
Smiles
N[C@H](Cc1ccc(O)c(O)c1)C(O)=O
Molecular Formula
C9H11NO4
Molecular Weight
197.19
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC431680 20 µg
Neurofascin (NFASC) (NM_001160331) Human Over-expression Lysate
Sign In for Pricing
View Details 
TMB_KTELL_SUPP3_1 10 x 2 mL Vials
Potassium Tellurite Sterile Solution 3.5% 10 x 2 ml Vials
Sign In for Pricing
View Details 
MBS256812-01 1 µmol
beta-Nicotinamide-8-(2-azidobenzylthio)adenine dinucleotide (8-oN?-BT-NAD?), sodium salt
Sign In for Pricing
View Details MBS256812-02 5x 1 µmol
beta-Nicotinamide-8-(2-azidobenzylthio)adenine dinucleotide (8-oN?-BT-NAD?), sodium salt
Sign In for Pricing
View Details MBS6406576-01 0.1 mL
ANXA2 (Annexin A2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV) (APC)
Sign In for Pricing
View Details MBS6406576-02 5x 0.1 mL
ANXA2 (Annexin A2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV) (APC)
Sign In for Pricing
View Details